Cytokinetics (CYTK) PT Lowered to $55 at JPMorgan
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $65.81 -2.63%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
JPMorgan analyst Tessa Romero lowered the price target on Cytokinetics (NASDAQ: CYTK) to $55.00 (from $64.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- HSBC Holdings Plc. (5:HK) (HSBC) PT Raised to GBP172 at Citi
- IGO Limited (IGO.AU) (IPGDF) PT Lowered to AUD6.90 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
